Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| §112 only | 2 (50%) |
| No statute on record | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SANG, HONG | 1 | 54.7% | +61.8% |
| BERHANE, SELAM | 1 | 61.3% | +55.5% |
| WEHBE, ANNE MARIE SABRINA | 1 | 57.6% | +42.1% |
| CANELLA, KAREN A | 1 | 62.6% | +32.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17820913 | CONDITIONALLY ACTIVE POLYPEPTIDES | CANELLA, KAREN A | 51d overdue |
| 18002010 | CONDITIONALLY ACTIVE ANTI-CD46 ANTIBODIES, ANTIBODY FRAGMENTS, THEIR IMMUNOCONJUGATES AND USES THEREOF | BERHANE, SELAM | 45d overdue |
| 18061197 | CONDITIONALLY ACTIVE CHIMERIC ANTIGEN RECEPTORS FOR MODIFIED T-CELLS | WEHBE, ANNE MARIE SABRINA | 13d |
| 18002064 | CONDITIONALLY ACTIVE ANTI-NECTIN-4 ANTIBODIES | SANG, HONG | 19d |
| Art Unit | Apps |
|---|---|
| 1646 | 1 |
| 1675 | 1 |
| 1634 | 1 |
| 1643 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18002064 | CONDITIONALLY ACTIVE ANTI-NECTIN-4 ANTIBODIES | SANG, HONG | 1646 | §112 | Non-Final OA | 19d | Pending | Dec 16, 2022 |
| 18002010 | CONDITIONALLY ACTIVE ANTI-CD46 ANTIBODIES, ANTIBODY FRAGMENTS, THEIR IMMUNOCONJUGATES AND USES THEREOF | BERHANE, SELAM | 1675 | §112 | Non-Final OA | 45d overdue | Pending | Dec 15, 2022 |
| 18061197 | CONDITIONALLY ACTIVE CHIMERIC ANTIGEN RECEPTORS FOR MODIFIED T-CELLS | WEHBE, ANNE MARIE SABRINA | 1634 | §103 | Final Rejection | 13d | Pending | Dec 02, 2022 |
| 17820913 | CONDITIONALLY ACTIVE POLYPEPTIDES | CANELLA, KAREN A | 1643 | Other | Non-Final OA | 51d overdue | Pending | Aug 19, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial